Health

Health

Litigators jockey for advantage as MDL 3094, 3163 GLP-1 court cases maneuver through pretrial

Attorneys on both sides of MDL 3094 and MDL 3163 are maneuvering and jockeying for position as multi-district litigation against the makers of GLP-1 drugs including Ozempic, Wegovy, Rybelsus, Trulicity and Mounjaro edges closer to actual testimony. The cases break down into two categories: those claiming gastrointestinal injury

Health

GLP-1 Lawsuit & News Tracker: Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity

The GLP-1 family of drugs might be the biggest thing since AI. There have been unexpected benefits and about as many unexpected problems.

Health

$50 Medicare GLP-1 'bridge' presents a difficult entry process

The GLP-1 "bridge" is confusing to get into and its benefits are questionable given its temporary nature.

Health

Extreme heat can be hard on your eyes, too

Heat waves can worsen dry eye by speeding tear evaporation and increasing dehydration.

Health

DOJ drops criminal baby-formula probe; Abbott avoids charges

Senior feds terminate criminal investigation of Abbott Labs baby-formula contamination.

Health

Benadryl is still everywhere. Brain-health warnings haven’t slowed its use

The popular over-the-counter medicine is easy to buy, but geriatric experts have warned for years that diphenhydramine can be risky for older adults

Seniors

Medicare opens first weight-loss coverage at $50 a month

A new pilot Medicare program, "set to continue through 2027, will allow older adults to access GLP-1 medications for $50 per month" — the first time the program will cover them specifically for weight loss,

Health

FDA cracks down on telehealth weight-loss drug marketing

Regulators say some firms falsely implied their products were equivalent to FDA-approved medications such as Wegovy, Ozempic, Zepbound, and Mounjaro. The U.S. Food and Drug Administration has intensified its campaign against the booming online weight-loss drug industry, issuing warning letters to 25 telehealth companies that allegedly made

Seniors

If you want out of Medicare Advantage, a 12-month calendar is your best friend

Seniors are finding that insurers are denying prior authorization for long-term care and rehabilitation. Are they trapped? Some are, but not everyone.

Seniors

Leaving Medicare Advantage during your 12-month trial

A step-by-step consumer guide to protecting your right to a Medigap policy A ConsumerNews.ai consumer resource — June 17, 2026 As The Outraged Consumer and others reported earlier, many of the largest Medicare Advantage insurers are denying prior authorization for long-term and rehabilitative care. This is driving

Insurance

Trump plan for healthcare: borrow from your insurance company

UnitedHealth jumps on the idea but economists say it's "profoundly disconnected" from reality

Health

Listeria outbreak tied to soft cheese kills one, sickens seven; more products may be affected

The outbreak started on New York's Long Island; pregnant women are at heightened risk